Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Brian Smith Insider Profile
4 Followers
Jeffrey Brian Smith, Director at NeonMind Biosciences Inc, holds 2.00M shares in NeonMind Biosciences Inc (Ticker: TSE:LCR).
Jeffrey Brian Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jeffrey Brian Smith's holdings
Insider Roles
Director
Roles that Jeffrey Brian Smith holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jeffrey Brian Smith
Jeffrey Brian Smith's Trading History
List of latest transactions for each holding click on a transaction to see Jeffrey Brian Smith's performance on stock
You May Also Like
Jeffrey Brian Smith insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Brian Smith?
The percentage of profitable transactions made by Jeffrey Brian Smith is ―.
What is the average return per transaction made by Jeffrey Brian Smith?
The average return per transaction made by Jeffrey Brian Smith is ―.
What stocks does Jeffrey Brian Smith hold?
Jeffrey Brian Smith holds: TSE:LCR stocks.
What was Jeffrey Brian Smith’s latest transaction?
Jeffrey Brian Smith latest transaction was an Uninformative Buy of ―.
What was Jeffrey Brian Smith's most profitable transaction?
Jeffrey Brian Smith’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jeffrey Brian Smith's role in NeonMind Biosciences Inc?
Jeffrey Brian Smith's role in NeonMind Biosciences Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.